Lupin

Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio

Read more

Lupin Research Park R&D facility in Pune secures LEED Platinum Certification

Read more

Lupin gains tentative USFDA nod for Sitagliptin and Metformin Hydrochloride Tablets

Read more

Lupin’s ESG score rises to 76 in S&P Global ESG Ratings

Read more

Lupin and NAPCON host Walkathon to raise COPD awareness

Read more

Lupin receives FDA approval for generic version of Adderall XR

Read more

Lupin launches Bumetanide injection USP in the United States

Read more

Lupin launches Humrahi with focus on diabetes and heart health

Read more

Lupin receives tentative U.S. FDA approval for Raltegravir tablets

Read more

The quest for quality continues

Read more